参考文献/References:
[1]Newton ER,Akerman AW,Strassle PD,et al. Association of fluoroquinolone use with short-term risk of development of aortic aneurysm[J]. JAMA Surg,2021,156(3):264-272.
[2]张波,王文艳,陈蒙华. 氟喹诺酮抗生素与主动脉瘤/夹层发生和发展的关系[J]. 临床心血管病杂志,2020,36(12):1083-1087.
[3]管玉瑶,刘雪梅,杨静,等. 某院氟喹诺酮类注射液高风险因素人群用药安全性分析[J]. 药物流行病学杂志,2020,29(10):666-669.
[4]Pasternak B,Inghammar M,Svanstr?m H,et al. Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study[J]. BMJ,2018,360:k678.
[5]Lee CC,Lee MG,Hsieh R,et al. Oral fluoroquinolone and the risk of aortic dissection[J]. J Am Coll Cardiol,2018,72(12):1369-1378.
[6]Sidloff D,Choke E,Stather P,et al. Mortality from thoracic aortic diseases and associations with cardiovascular risk factors[J]. Circulation,2014,130(25):2287-2294.
[7]Schmitz-Rixen T,Keese M,Hakimi M,et al. Ruptured abdominal aortic aneurysm epidemiology,predisposing factors,and biology[J]. Langenbecks Arch Surg,2016,401(3):275-288.
[8]Ezelarab HAA,Abbas SH,Hassan HA,et al. Recent updates of fluoroquinolones as antibacterial agents[J]. Arch Pharm,2018,351(9):e1800141.
[9] Jun C,Fang B. Current progress of fluoroquinolones-increased risk of aortic aneurysm and dissection[J]. BMC Cardiovasc Disord,2021,21(1):470.
[10]Zhang GF,Zhang S,Pan B,et al. 4-Quinolone derivatives and their activities against Gram positive pathogens[J]. Eur J Med Chem,2018,1(143):710-723.
[11]Zhang GF,Liu X,Zhang S,et al. Ciprofloxacin derivatives and their antibacterial activities[J]. Eur J Med Chem,2018,25(146):599-612.
[12]Kuula LSM,Viljemaa KM,Backman JT,et al. Fluoroquinolone-related adverse events resulting in health service use and costs:a systematic review[J]. PLoS One,2019,14(4):e0216029.
[13]Noman AT,Qazi AH,Alqasrawi M,et al. Fluoroquinolones and the risk of aortopathy:a systematic review and meta-analysis[J]. Int J Cardiol,2019:1(274):299-302.
[14]Lee CC,Lee MT,Chen YS,et al. Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone[J]. JAMA Intern Med,2015,175(11):1839-1847.
[15]Daneman N,Lu H,Redelmeier DA,et al. Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study[J]. BMJ Open,2015,5(11):e010077.
[16] Latif A,Ahsan MJ,Kapoor V,et al. Fluoroquinolones and the risk of aortopathy:a systematic review and meta-analysis[J]. WMJ,2020,119(3):185-189.
[17]Frankel WC,Trautner BW,Spiegelman A,et al. Patients at risk for aortic rupture often exposed to fluoroquinolones during hospitalization[J]. Antimicrob Agents Chemother,2019,63(2):e01712-18.
[18]Howard DP,Banerjee A,Fairhead JF,et al. Age-specific incidence,risk factors and outcome of acute abdominal aortic aneurysms in a defined population[J]. Br J Surg,2015,102(8):907-915.
[19]Dolladille C,Chrétien B,Sassier M,et al. Fluoroquinolone and aortic dissection:is it a class effect[J]. J Am Coll Cardiol,2019,73(3):382-383.
[20]LeMaire SA,Zhang L,Luo W,et al. Effect of ciprofloxacin on susceptibility to aortic dissection and rupture in mice[J]. JAMA Surg,2018,153(9):e181804.
[21]Ogino H,Fujii M,Ono M,et al. In vivo and in vitro effects of fluoroquinolones on lipopolysaccharide-induced pro-inflammatory cytokine production[J]. J Infect Chemother,2009,15(3):168-173.
[22]Bouissou C, Lacolley P, Dabire H,et al. Increased stiffness and cell-matrix interactions of abdominal aorta in two experimental nonhypertensive models:long-term chemically sympathectomized and sinoaortic denervated rats[J]. J Hypertens,2014,32(3):652-658.
[23]Rodríguez-Carrio J, Cerro-Pardo I, Lindholt JS,et al. Malondialdehyde-modified HDL particles elicit a specific IgG response in abdominal aortic aneurysm[J]. Free Radic Biol Med,2021,174:171-181.
[24]Hadi T,Boytard L,Silvestro M,et al. Macrophage-derived netrin-1 promotes abdominal aortic aneurysm formation by activating MMP3 in vascular smooth muscle cells[J]. Nat Commun,2018,9(1):5022.
[25]Guzzardi DG, Teng G, Kang S,et al. Induction of human aortic myofibroblast-mediated extracellular matrix dysregulation:a potential mechanism of fluoroquinolone-associated aortopathy[J] . J Thorac Cardiovasc Surg,2019,157(1):109-119.e2.
[26]Son N,Choi E,Chung SY,et al. Risk of aortic aneurysm and aortic dissection with the use of fluoroquinolones in Korea: a nested case-control study[J]. BMC Cardiovasc Disord,2022,22(1):44.
[27]Chen YY,Yang SF,Yeh HW,et al. Association between aortic aneurysm and aortic dissection with fluoroquinolones use in patients with urinary tract infections:a population-based cohort study[J]. J Am Heart Assoc,2022,11(6):e023267.
[28]Smart DJ, Halicka HD, Traganos F,et al. Ciprofloxacin-induced G2 arrest and apoptosis in TK6 lymphoblastoid cells is not dependent on DNA double-strand break formation[J]. Cancer Biol Ther,2008,7(1):113-119.
[29]Pommicr Y,Sun Y,Huang SN,et al. Roles of eukaryotic topoisomerases in transcription,replication and genomic stability[J]. Nat Rev Mol Cell Biol,2016:17(11):703-721.
[30]Lim EJ, Yoon YJ, Heo J,et al. Ciprofloxacin enhances TRAIL-induced apoptosis in lung cancer cells by upregulating the expression and protein stability of death receptors through CHOP expression[J]. Int J Mol Sci,2018,19(10):3187.